Metastatic Breast Cancer: Still a lot to be done

Although there is no cure for metastatic breast cancer (MBC), pharma innovation has helped to increase survivorship. However, patients with MBC face a number of challenges and inequalities across Europe, from screening to social discrimination and lack of knowledge.

Some 355,000 women in the EU have been diagnosed with breast cancer in 2020, however, it cannot be estimated how many have developed the advanced form.

Citing health technology assessment studies, EU lawmaker Frances Fitzgerald told EURACTIV that treating metastatic breast cancer is about ten times more expensive than dealing with early breast cancer.

“There is work to be done right across Europe,” she said.

In this Special Report, EURACTIV and its network analyse the different obstacles MBC patients face across Europe, as well as the opportunities arising from the European Commission’s push for an EU-wide plan to tackle cancer.

Download PDF  

Subscribe to our newsletters

Subscribe